TIMBER PHARMACEUTICALS INC (TMBR) Stock Analyst Earnings Estimates
NYSEARCA:TMBR - NYSE Arca - US8870802084 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 890K | 80K -91.01% | -100.00% | ||
| EBITDA YoY % growth | -9.63M 41.46% | -10.65M -10.59% | -19.24M -80.66% | N/A | N/A | |
| EBIT YoY % growth | -9.69M 41.31% | -10.65M -9.91% | -19.24M -80.66% | -16.319M 15.18% | -18.36M -12.51% | |
| Operating Margin | N/A | -1,196.63% | -24,050.00% | N/A | N/A | |
| EPS YoY % growth | -9.91 40.60% | N/A -58.74% | N/A 98.77% | -5.30 -2,636.84% | -5.62 -5.96% |
All data in USD
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.33 | -1.44 -8.95% | -1.54 -22.24% | -1.37 -6.35% | -1.29 3.08% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -4.182M -17.14% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | -1.26 83.20% | -0.81 | -0.45 | -56.37% |
| Q1 2023 Q2Q % growth | -1.32 47.20% | -1.19 | -0.13 | -10.61% |
| Q3 2022 Q2Q % growth | -1.52 -1,800.00% | % | ||
| Q2 2022 Q2Q % growth | -7.50 -9,275.00% | -2.04 | -5.46 | -267.65% |
| Q1 2022 Q2Q % growth | -2.50 -86.57% | -2.04 | -0.46 | -22.55% |
| Q3 2021 Q2Q % growth | -0.08 95.24% | % | ||
| Q2 2021 Q2Q % growth | -0.08 96.97% | % | ||
| Q1 2021 Q2Q % growth | -1.34 -30.45% | -0.61 | -0.73 | -118.95% |
| Q4 2020 Q2Q % growth | -1.03 65.76% | -0.61 | -0.42 | -67.84% |
| Q3 2020 Q2Q % growth | -1.68 | -0.73 | -0.95 | -128.76% |
| Q2 2020 Q2Q % growth | -2.64 56.00% | -0.86 | -1.78 | -208.12% |
| Q1 2020 Q2Q % growth | -1.03 82.88% | -0.98 | -0.05 | -4.90% |
| Q4 2019 Q2Q % growth | -3.00 | -2.69 | -0.31 | -11.41% |
| Q3 2019 Q2Q % growth | -1.68 | -4.10 | 2.42 | 59.03% |
| Q2 2019 Q2Q % growth | -6.00 | -3.18 | -2.82 | -88.54% |
| Q1 2019 Q2Q % growth | -6.00 | -6.12 | 0.12 | 1.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | 204K | -204K | -100.00% | |
| Q1 2023 Q2Q % growth | -100.00% | 204K | -204K | -100.00% |
| Q4 2022 Q2Q % growth | -100.00% | % | ||
| Q3 2022 Q2Q % growth | -100.00% | % | ||
| Q2 2022 Q2Q % growth | -100.00% | 153K | -153K | -100.00% |
| Q1 2022 Q2Q % growth | 80K 100.00% | 153K | -73K | -47.71% |
| Q4 2021 Q2Q % growth | 190K 90.00% | % | ||
| Q3 2021 Q2Q % growth | 270K -15.63% | % | ||
| Q1 2020 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | -76.27% |
| Revenue | N/A | N/A | N/A | -100% |